Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4235-4245
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4235
Table 2 Outcome of mild disease patients after the first 2 years of study entry
n (%)
Starting immunomodulator8 (27.6)
Starting biologic0
Starting immunomodulator and biologic0
Surgery0
Continued on minimal therapy21 (72.4)